| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LAFAU | LAFAYETTE ACQUISITION CORP | N/A | $10.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| EFTY | ETOILES CAPITAL GROUP CO LTD | N/A | $15.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| KLAR | KLARNA GROUP PLC | N/A | $36.91 | $49.54 | 34.21% | Strong Buy | 13 | N/A | N/A | 34.87% | 4.25% | |||
| DKI | DARKIRIS INC | N/A | $0.53 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| STKE | SOL STRATEGIES INC | N/A | $2.85 | N/A | N/A | N/A | N/A | N/A | N/A | -20.06% | -12.47% | |||
| CHECU | CHENGHE ACQUISITION III CO | N/A | $9.98 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| YCY.U | AA MISSION ACQUISITION CORP II | N/A | $9.99 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| DMIIU | DRUGS MADE IN AMERICA ACQUISITION II CORP | N/A | $10.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| LKSPU | LAKE SUPERIOR ACQUISITION CORP | N/A | $10.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| DLXY | DELIXY HOLDINGS LTD | N/A | $1.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| LBRX | LB PHARMACEUTICALS INC | N/A | $16.50 | $46.33 | 180.81% | Strong Buy | 3 | N/A | N/A | N/A | -387.18% | |||
| EMPG | EMPRO GROUP INC | N/A | $17.36 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| CEPF | CANTOR EQUITY PARTNERS IV INC | N/A | $10.50 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| NSRX | NASUS PHARMA LTD | N/A | $8.00 | $22.00 | 175.00% | Strong Buy | 1 | N/A | N/A | N/A | N/A | |||
| AEXA | AMERICAN EXCEPTIONALISM ACQUISITION CORP A | N/A | $11.31 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.